Notification/Circular No.: S.O. 3710(E) [PN/280/148/2026/F] dated July 8, 2026
Applicable Act/Rule: Drugs (Prices Control) Order, 2013
Applicable Section/Rule: Paragraphs 5, 11 and 15
NPPA, in exercise of powers under paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013 read with S.O. 1394(E) dated 30.05.2013, S.O. 5249(E) dated 11.11.2022 and S.O. 3516(E) dated 30.06.2026, has fixed the retail price of Calcium and Vitamin D3 Tablets IP (each film-coated tablet containing Calcium Carbonate IP equivalent to Elemental Calcium 500 mg and Vitamin D3 IP 2000 IU), manufactured by M/s Akums Drugs & Pharmaceuticals Ltd./M/s Eris Lifesciences Ltd., at Rs. 8.93 per tablet, exclusive of Goods and Services Tax, if any.
Notes specify: the manufacturer of the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall not fix a retail price exceeding the notified price; this price is applicable only to the named manufacturer/marketer subject to fulfilment of statutory licensing requirements; GST may be added only if actually paid or payable to Government; a price list in Form-V shall be issued under paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and to State Drug Controllers and dealers; retailers/distributors shall display the price list per paragraph 24(4); and non-compliance renders the manufacturer/marketing company liable to deposit the overcharged amount with interest under the DPCO, 2013 read with the Essential Commodities Act, 1955.
Disclaimer: The information contained in this Article is intended solely for personal non-commercial use of the user who accepts full responsibility of its use. The information in the article is general in nature and should not be considered to be legal, tax, accounting, consulting or any other professional advice. We make no representation or warranty of any kind, express or implied regarding the accuracy, adequacy, reliability or completeness of any information on our page/article.
